Details for Patent: 4,599,353
✉ Email this page to a colleague
Summary for Patent: 4,599,353
Title: | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma |
Abstract: | Ocular hypertension and glaucoma can be effectively controlled in primates through topical application of an effective amount of an eicosanoid or an eicosanoid derivative to the surface of an afflicted eye. Eicosanoids, particularly the prostaglandins PGE.sub.2 and PGF.sub.2.alpha., and derivatives thereof, have been found effective in quantities less than about 1000 .mu.g per eye. Ophthalmic compositions containing C.sub.1 to C.sub.5 alkyl esters of PGF.sub.2.alpha. are presently preferred for use in treating ocular hypertension and glaucoma in primates, including man. |
Inventor(s): | Bito; Laszlo Z. (New York, NY) |
Assignee: | The Trustees of Columbia University in the City of New York (New York, NY) |
Application Number: | 06/374,165 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 4,599,353
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 4,599,353
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 560189 | ⤷ Try a Trial | |||
Canada | 1208560 | ⤷ Try a Trial | |||
Germany | 3369068 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |